{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:04:20Z","timestamp":1784649860574,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Ningbo Natural Science Foundation","award":["2024J356"],"award-info":[{"award-number":["2024J356"]}]},{"name":"Ningbo Health Science and Technology Program Project","award":["2024Y11"],"award-info":[{"award-number":["2024Y11"]}]},{"name":"the Zhu Xiu Shan Talent Project of Ningbo No.2 Hospital","award":["2023HMJQ34"],"award-info":[{"award-number":["2023HMJQ34"]}]},{"name":"Medical and Health Science Program of Zhejiang Province","award":["2025HY0999"],"award-info":[{"award-number":["2025HY0999"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06072-8","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:23:57Z","timestamp":1784647437000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Study on the Effects of Intranasally Administered Liquid Crystalline Nanoparticles Loaded with Salvianolic Acid B in Vascular Dementia"],"prefix":"10.1007","volume":"63","author":[{"given":"Ningwei","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisuhang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"6072_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cells14080609","author":"AY Altahrawi","year":"2025","unstructured":"Altahrawi AY, James AW, Shah ZA (2025) The role of oxidative stress and inflammation in the pathogenesis and treatment of vascular dementia. Cells. https:\/\/doi.org\/10.3390\/cells14080609","journal-title":"Cells"},{"issue":"10004","key":"6072_CR2","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/S0140-6736(15)00463-8","volume":"386","author":"JT O'Brien","year":"2015","unstructured":"O\u2019Brien JT, Thomas A (2015) Vascular dementia. Lancet 386(10004):1698\u20131706. https:\/\/doi.org\/10.1016\/S0140-6736(15)00463-8","journal-title":"Lancet"},{"issue":"5","key":"6072_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70403","volume":"31","author":"Y Lu","year":"2025","unstructured":"Lu Y, Cheng L, Xiong Y, Huang C, Liu Z, Shen C, Wang H, Qiu Y et al (2025) NLRP3 inflammasome in vascular dementia: regulatory mechanisms, functions, and therapeutic implications: a comprehensive review. CNS Neurosci Ther 31(5):e70403. https:\/\/doi.org\/10.1111\/cns.70403","journal-title":"CNS Neurosci Ther"},{"issue":"6","key":"6072_CR4","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1134\/S0026893324060049","volume":"58","author":"C Fang","year":"2024","unstructured":"Fang C, Qian L, Ma N (2024) Mechanism of oxidative stress inducing pyroptosis by activating the NLRP3\/Caspase-1\/GSDMD pathway in lens epithelial cells under high glucose environment. Mol Biol 58(6):1241\u20131249","journal-title":"Mol Biol"},{"issue":"9","key":"6072_CR5","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41419-019-1883-8","volume":"10","author":"X Xia","year":"2019","unstructured":"Xia X, Wang X, Cheng Z, Qin W, Lei L, Jiang J, Hu J (2019) The role of pyroptosis in cancer: pro-cancer or pro-\u201chost\u201d? Cell Death Dis 10(9):650. https:\/\/doi.org\/10.1038\/s41419-019-1883-8","journal-title":"Cell Death Dis"},{"issue":"11","key":"6072_CR6","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/s41423-022-00922-w","volume":"19","author":"A Akbal","year":"2022","unstructured":"Akbal A, Dernst A, Lovotti M, Mangan MSJ, McManus RM, Latz E (2022) How location and cellular signaling combine to activate the NLRP3 inflammasome. Cell Mol Immunol 19(11):1201\u20131214. https:\/\/doi.org\/10.1038\/s41423-022-00922-w","journal-title":"Cell Mol Immunol"},{"key":"6072_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109595","volume":"121","author":"Y Fang","year":"2020","unstructured":"Fang Y, Tian S, Pan Y, Li W, Wang Q, Tang Y, Yu T, Wu X et al (2020) Pyroptosis: a new frontier in cancer. Biomed Pharmacother 121:109595. https:\/\/doi.org\/10.1016\/j.biopha.2019.109595","journal-title":"Biomed Pharmacother"},{"key":"6072_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ph16081182","author":"A Alattar","year":"2023","unstructured":"Alattar A, Alshaman R, Althobaiti YS, Soliman GM, Ali HS, Khubrni WS, Koh PO, Rehman NU et al (2023) Quercetin alleviated inflammasome-mediated pyroptosis and modulated the mTOR\/P70S6\/P6\/eIF4E\/4EBP1 pathway in ischemic stroke. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph16081182","journal-title":"Pharmaceuticals (Basel)"},{"key":"6072_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106333","volume":"188","author":"W Hao","year":"2023","unstructured":"Hao W, Feng C (2023) Research progress on pyroptosis and its effect on the central nervous system. Neurobiol Dis 188:106333","journal-title":"Neurobiol Dis"},{"key":"6072_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119248","volume":"272","author":"C Nie","year":"2021","unstructured":"Nie C, Ding X, A R, Zheng M, Li Z, Pan S, Yang W (2021) Hydrogen gas inhalation alleviates myocardial ischemia-reperfusion injury by the inhibition of oxidative stress and NLRP3-mediated pyroptosis in rats. Life Sci 272:119248. https:\/\/doi.org\/10.1016\/j.lfs.2021.119248","journal-title":"Life Sci"},{"key":"6072_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1681358","volume":"16","author":"Y Shao","year":"2025","unstructured":"Shao Y, Zhai L, Jiang S, Sun F, Liu X (2025) Salvianolic acid B: a promising cardioprotective agent. Front Immunol 16:1681358. https:\/\/doi.org\/10.3389\/fimmu.2025.1681358","journal-title":"Front Immunol"},{"issue":"10","key":"6072_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1030","volume":"11","author":"XF Zheng","year":"2023","unstructured":"Zheng XF, Zhang XJ, Dong LP, Zhao JR, Zhang C, Chen R (2023) Neuroprotective mechanism of salvianolic acid B against cerebral ischemia-reperfusion injury in mice through downregulation of TLR4, p-p38MAPK, p-JNK, NF-kappaB, and IL-1beta. Immun Inflamm Dis 11(10):e1030. https:\/\/doi.org\/10.1002\/iid3.1030","journal-title":"Immun Inflamm Dis"},{"issue":"11","key":"6072_CR13","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1038\/s41401-023-01125-3","volume":"44","author":"MD Wang","year":"2023","unstructured":"Wang MD, Zhang S, Liu XY, Wang PP, Zhu YF, Zhu JR, Lv CS, Li SY et al (2023) Salvianolic acid B ameliorates retinal deficits in an early-stage Alzheimer\u2019s disease mouse model through downregulating BACE1 and Abeta generation. Acta Pharmacol Sin 44(11):2151\u20132168. https:\/\/doi.org\/10.1038\/s41401-023-01125-3","journal-title":"Acta Pharmacol Sin"},{"key":"6072_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114461","volume":"153","author":"HD Li","year":"2025","unstructured":"Li HD, Zheng JY, Tan KW, Su JX, Chen W, Pang RK, Wu GL, Qiu YH et al (2025) Salvianolic acid B (SalB) improves high-fat diet (HFD)-caused cognitive impairment in mice by modulating the Trem2\/Dap12 pathway in vivo and in vitro. Int Immunopharmacol 153:114461. https:\/\/doi.org\/10.1016\/j.intimp.2025.114461","journal-title":"Int Immunopharmacol"},{"key":"6072_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1606146","volume":"16","author":"S Bi","year":"2025","unstructured":"Bi S, Liu S, Zhu K, Gao D, Chen L, Yu C, Liang G (2025) Preclinical and experimental evidence of salvianolic acid B in the treatment of neurological diseases. Front Pharmacol 16:1606146. https:\/\/doi.org\/10.3389\/fphar.2025.1606146","journal-title":"Front Pharmacol"},{"issue":"4","key":"6072_CR16","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1159\/000481849","volume":"43","author":"X Ma","year":"2017","unstructured":"Ma X, Xu W, Zhang Z, Liu N, Yang J, Wang M, Wang Y (2017) Salvianolic acid B ameliorates cognitive deficits through IGF-1\/Akt pathway in rats with vascular dementia. Cell Physiol Biochem 43(4):1381\u20131391. https:\/\/doi.org\/10.1159\/000481849","journal-title":"Cell Physiol Biochem"},{"key":"6072_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156260","volume":"136","author":"X-H Wei","year":"2025","unstructured":"Wei X-H, Chen J, Wu X-F, Zhang Q, Xia G-Y, Chu X-Y, Xia H, Lin S et al (2025) Salvianolic acid B alleviated myocardial ischemia-reperfusion injury via modulating SIRT3-mediated crosstalk between mitochondrial ROS and NLRP3. Phytomedicine 136:156260. https:\/\/doi.org\/10.1016\/j.phymed.2024.156260","journal-title":"Phytomedicine"},{"key":"6072_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.572373","volume":"11","author":"Z Xiao","year":"2020","unstructured":"Xiao Z, Liu W, Mu YP, Zhang H, Wang XN, Zhao CQ, Chen JM, Liu P (2020) Pharmacological effects of salvianolic acid B against oxidative damage. Front Pharmacol 11:572373. https:\/\/doi.org\/10.3389\/fphar.2020.572373","journal-title":"Front Pharmacol"},{"issue":"1","key":"6072_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.neulet.2008.04.097","volume":"439","author":"TM Ross","year":"2008","unstructured":"Ross TM, Zuckermann RN, Reinhard C, Frey WH 2nd (2008) Intranasal administration delivers peptoids to the rat central nervous system. Neurosci Lett 439(1):30\u201333. https:\/\/doi.org\/10.1016\/j.neulet.2008.04.097","journal-title":"Neurosci Lett"},{"issue":"8","key":"6072_CR20","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-024-02954-z","volume":"25","author":"K Akbar","year":"2024","unstructured":"Akbar K, Rehman MU, Shah FA, Younas S, Al-Otaibi JS, Khan H (2024) Paroxetine loaded nanostructured lipid carriers based in-situ gel for brain delivery via nasal route for enhanced anti-depressant effect: in vitro prospect and in vivo efficacy. AAPS PharmSciTech 25(8):248. https:\/\/doi.org\/10.1208\/s12249-024-02954-z","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"6072_CR21","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12951-023-02150-4","volume":"21","author":"D Xu","year":"2023","unstructured":"Xu D, Gao LN, Song XJ, Dong QW, Chen YB, Cui YL, Wang Q (2023) Enhanced antidepressant effects of BDNF-quercetin alginate nanogels for depression therapy. J Nanobiotechnol 21(1):379. https:\/\/doi.org\/10.1186\/s12951-023-02150-4","journal-title":"J Nanobiotechnol"},{"key":"6072_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.matdes.2026.115627","volume":"263","author":"G Fan","year":"2026","unstructured":"Fan G, Zhang A, Zhao A, Gao Y, Rong Y, Xin R, He L, Qi S (2026) Biomimetic propofol liposomes alleviate ischemic stroke by targeting ferroptosis via EGFR\/Nrf2 pathway activation. Mater Des 263:115627. https:\/\/doi.org\/10.1016\/j.matdes.2026.115627","journal-title":"Mater Des"},{"key":"6072_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e19779","author":"S Sohail","year":"2023","unstructured":"Sohail S, Shah FA, Zaman S, Almari AH, Malik I, Khan SA, Alamro AA, Zeb A et al (2023) Melatonin delivered in solid lipid nanoparticles ameliorated its neuroprotective effects in cerebral ischemia. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e19779","journal-title":"Heliyon"},{"issue":"6","key":"6072_CR24","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1021\/acsabm.4c00112","volume":"7","author":"BF Far","year":"2024","unstructured":"Far BF, Safaei M, Pourmolaei A, Adibamini S, Shirdel S, Shirdel S, Emadi R, Kaushik AK (2024) Exploring curcumin-loaded lipid-based nanomedicine as efficient targeted therapy for Alzheimer\u2019s diseases. ACS Appl Bio Mater 7(6):3535\u20133555. https:\/\/doi.org\/10.1021\/acsabm.4c00112","journal-title":"ACS Appl Bio Mater"},{"key":"6072_CR25","doi-asserted-by":"publisher","unstructured":"AV S, Nair A, Raj D, PA G, PS P, SK\u00a0V  (2024) Cubosomes as versatile lipid nanocarriers for neurological disorder therapeutics: a comprehensive review. Naunyn Schmiedebergs Arch Pharmacol 397(6):3729\u20133746. https:\/\/doi.org\/10.1007\/s00210-023-02879-7","DOI":"10.1007\/s00210-023-02879-7"},{"key":"6072_CR26","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.2147\/IJN.S32599","volume":"7","author":"N Zeng","year":"2012","unstructured":"Zeng N, Gao X, Hu Q, Song Q, Xia H, Liu Z, Gu G, Jiang M et al (2012) Lipid-based liquid crystalline nanoparticles as oral drug delivery vehicles for poorly water-soluble drugs: cellular interaction and in vivo absorption. Int J Nanomedicine 7:3703\u20133718. https:\/\/doi.org\/10.2147\/IJN.S32599","journal-title":"Int J Nanomedicine"},{"key":"6072_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15051421","author":"JSL Leu","year":"2023","unstructured":"Leu JSL, Teoh JJX, Ling ALQ, Chong J, Loo YS, Mat Azmi ID, Zahid NI, Bose RJC et al (2023) Recent advances in the development of liquid crystalline nanoparticles as drug delivery systems. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15051421","journal-title":"Pharmaceutics"},{"key":"6072_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2025.102823","volume":"66","author":"D Patel","year":"2025","unstructured":"Patel D, Wairkar S (2025) Lyotropic liquid crystalline nanoparticles of morin: an approach to improve pharmacokinetics and brain disposition in rats via nose-to-brain pathway. Nanomedicine (Lond) 66:102823. https:\/\/doi.org\/10.1016\/j.nano.2025.102823","journal-title":"Nanomedicine (Lond)"},{"key":"6072_CR29","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jconrel.2017.09.001","volume":"268","author":"AR Khan","year":"2017","unstructured":"Khan AR, Liu M, Khan MW, Zhai G (2017) Progress in brain targeting drug delivery system by nasal route. J Control Release 268:364\u2013389. https:\/\/doi.org\/10.1016\/j.jconrel.2017.09.001","journal-title":"J Control Release"},{"key":"6072_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123019","volume":"640","author":"AVP Silvestrini","year":"2023","unstructured":"Silvestrini AVP, Garcia Praca F, Leite MN, de Abreu Fantini MC, Frade MAC, Badra Bentley MVL (2023) Liquid crystalline nanoparticles enable a multifunctional approach for topical psoriasis therapy by co-delivering triptolide and siRNAs. Int J Pharm 640:123019. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123019","journal-title":"Int J Pharm"},{"issue":"1","key":"6072_CR31","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s12035-025-05530-z","volume":"63","author":"HZ Ali","year":"2025","unstructured":"Ali HZ, Jahan S, Ilahi L, Siraj S, Zakria M, Ullah N, Ikram M, Khan AU et al (2025) Ambroxol\u2019s role in PTZ-induced anxiety-like conditions in mice: targeting neuroinflammation and oxidative stress via in vivo and in silico approaches. Mol Neurobiol 63(1):162. https:\/\/doi.org\/10.1007\/s12035-025-05530-z","journal-title":"Mol Neurobiol"},{"issue":"6","key":"6072_CR32","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-025-03169-6","volume":"26","author":"S Tafazzoli Mehrjardi","year":"2025","unstructured":"Tafazzoli Mehrjardi S, Tafaghodi M, Malek S, Yari D, Mohammadpour AH, Kamali H, Nokhodchi A (2025) Intranasal delivery of cetrorelix via lipid liquid crystal nanoparticles: characterization and pharmacokinetic studies in rats. AAPS PharmSciTech 26(6):176. https:\/\/doi.org\/10.1208\/s12249-025-03169-6","journal-title":"AAPS PharmSciTech"},{"key":"6072_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125396","volume":"673","author":"R Bo","year":"2025","unstructured":"Bo R, Wu J, Tao Y, Hong H, Peng W, Wang W, Wu W, Wang X et al (2025) Characterization of chitosan-coated PLGA nanoemulsion loaded with cepharanthine and inhibitory effect on Staphylococcus aureus pneumonia of mice. Int J Pharm 673:125396. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125396","journal-title":"Int J Pharm"},{"key":"6072_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10020057","author":"M Danaei","year":"2018","unstructured":"Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, Khorasani S, Mozafari MR (2018) Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics10020057","journal-title":"Pharmaceutics"},{"key":"6072_CR35","doi-asserted-by":"publisher","first-page":"1026743","DOI":"10.3389\/fbioe.2022.1026743","volume":"10","author":"X Xia","year":"2022","unstructured":"Xia X, Song X, Li Y, Hou W, Lv H, Li F, Li Y, Liu J et al (2022) Antibacterial and anti-inflammatory ZIF-8@Rutin nanocomposite as an efficient agent for accelerating infected wound healing. Front Bioeng Biotechnol 10:1026743. https:\/\/doi.org\/10.3389\/fbioe.2022.1026743","journal-title":"Front Bioeng Biotechnol"},{"key":"6072_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ph15040429","author":"M Chountoulesi","year":"2022","unstructured":"Chountoulesi M, Pispas S, Tseti IK, Demetzos C (2022) Lyotropic liquid crystalline nanostructures as drug delivery systems and vaccine platforms. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph15040429","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"6072_CR37","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jconrel.2011.03.033","volume":"153","author":"TH Nguyen","year":"2011","unstructured":"Nguyen TH, Hanley T, Porter CJ, Boyd BJ (2011) Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration. J Control Release 153(2):180\u2013186. https:\/\/doi.org\/10.1016\/j.jconrel.2011.03.033","journal-title":"J Control Release"},{"key":"6072_CR38","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.2147\/IJN.S439181","volume":"19","author":"J Koo","year":"2024","unstructured":"Koo J, Lim C, Oh KT (2024) Recent advances in intranasal administration for brain-targeting delivery: a comprehensive review of lipid-based nanoparticles and stimuli-responsive gel formulations. Int J Nanomedicine 19:1767\u20131807. https:\/\/doi.org\/10.2147\/IJN.S439181","journal-title":"Int J Nanomedicine"},{"key":"6072_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16101297","author":"J Torres","year":"2024","unstructured":"Torres J, Silva R, Farias G, Sousa Lobo JM, Ferreira DC, Silva AC (2024) Enhancing acute migraine treatment: exploring solid lipid nanoparticles and nanostructured lipid carriers for the nose-to-brain route. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics16101297","journal-title":"Pharmaceutics"},{"key":"6072_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262110666","author":"S Andrade","year":"2025","unstructured":"Andrade S, Ramalho MJ, Santos J, Santos S, Melo LDR, Guimaraes N, Ferraz MP, Azevedo NF et al (2025) PLGA nanoparticles double-decorated with a TAT peptide and folic acid to target Staphylococcus aureus. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms262110666","journal-title":"Int J Mol Sci"},{"key":"6072_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118407","volume":"333","author":"LL Fan","year":"2024","unstructured":"Fan LL, Fang H, Zheng JY, Qiu YH, Wu GL, Cai YF, Chen YB, Zhang SJ (2024) Taohong siwu decoction alleviates cognitive impairment by suppressing endoplasmic reticulum stress and apoptosis signaling pathway in vascular dementia rats. J Ethnopharmacol 333:118407. https:\/\/doi.org\/10.1016\/j.jep.2024.118407","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"6072_CR42","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12906-018-2345-z","volume":"18","author":"ZY Zhang","year":"2018","unstructured":"Zhang ZY, Liu Z, Deng HH, Chen Q (2018) Effects of acupuncture on vascular dementia (VD) animal models: a systematic review and meta-analysis. BMC Complement Altern Med 18(1):302. https:\/\/doi.org\/10.1186\/s12906-018-2345-z","journal-title":"BMC Complement Altern Med"},{"issue":"3","key":"6072_CR43","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1161\/STROKEAHA.122.038263","volume":"54","author":"AC Johnson","year":"2023","unstructured":"Johnson AC (2023) Hippocampal vascular supply and its role in vascular cognitive impairment. Stroke 54(3):673\u2013685. https:\/\/doi.org\/10.1161\/STROKEAHA.122.038263","journal-title":"Stroke"},{"issue":"3","key":"6072_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2024.e00342","volume":"21","author":"MY Yang","year":"2024","unstructured":"Yang MY, Liu Y, Yu YW, Gong BF, Ruan J, Fan HY (2024) Application of targeted liposomes-based salvianolic acid A for the treatment of ischemic stroke. Neurotherapeutics 21(3):e00342. https:\/\/doi.org\/10.1016\/j.neurot.2024.e00342","journal-title":"Neurotherapeutics"},{"issue":"5","key":"6072_CR45","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.18632\/aging.205593","volume":"16","author":"J Zhu","year":"2024","unstructured":"Zhu J, Du J, Kou W, Liu C, Fan J, Zhu Z, Deng L, Guan L et al (2024) Probucol protects against brain damage caused by intra-neural pyroptosis in rats with vascular dementia through inhibition of the Syk\/Ros pathway. Aging (Albany NY) 16(5):4363\u20134377. https:\/\/doi.org\/10.18632\/aging.205593","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"6072_CR46","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41536-023-00315-1","volume":"8","author":"D Wang","year":"2023","unstructured":"Wang D, Li B, Wang S, Hao Y, Wang H, Sun W, Cao J, Zhou X et al (2023) Engineered inhaled nanocatalytic therapy for ischemic cerebrovascular disease by inducing autophagy of abnormal mitochondria. NPJ Regen Med 8(1):44. https:\/\/doi.org\/10.1038\/s41536-023-00315-1","journal-title":"NPJ Regen Med"},{"issue":"11","key":"6072_CR47","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1007\/s11064-022-03696-9","volume":"47","author":"J Zhang","year":"2022","unstructured":"Zhang J, Zhang Y, Liu Y, Niu X (2022) Naringenin attenuates cognitive impairment in a rat model of vascular dementia by inhibiting hippocampal oxidative stress and inflammatory response and promoting N-methyl-D-aspartate receptor signaling pathway. Neurochem Res 47(11):3402\u20133413. https:\/\/doi.org\/10.1007\/s11064-022-03696-9","journal-title":"Neurochem Res"},{"issue":"1","key":"6072_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00507-5","volume":"6","author":"P Yu","year":"2021","unstructured":"Yu P, Zhang X, Liu N, Tang L, Peng C, Chen X (2021) Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther 6(1):128. https:\/\/doi.org\/10.1038\/s41392-021-00507-5","journal-title":"Signal Transduct Target Ther"},{"key":"6072_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109099","volume":"111","author":"LC Meng","year":"2022","unstructured":"Meng LC, Zheng JY, Qiu YH, Zheng L, Zheng JY, Liu YQ, Miao XL, Lu XY (2022) Salvianolic acid B ameliorates non-alcoholic fatty liver disease by inhibiting hepatic lipid accumulation and NLRP3 inflammasome in ob\/ob mice. Int Immunopharmacol 111:109099. https:\/\/doi.org\/10.1016\/j.intimp.2022.109099","journal-title":"Int Immunopharmacol"},{"key":"6072_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.541426","volume":"11","author":"Y Pang","year":"2020","unstructured":"Pang Y, Zhang PC, Lu RR, Li HL, Li JC, Fu HX, Cao YW, Fang GX et al (2020) Andrade-Oliveira salvianolic acid B modulates caspase-1-mediated pyroptosis in renal ischemia-reperfusion injury via Nrf2 pathway. Front Pharmacol 11:541426. https:\/\/doi.org\/10.3389\/fphar.2020.541426","journal-title":"Front Pharmacol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06072-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06072-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06072-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:23:58Z","timestamp":1784647438000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06072-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6072"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06072-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"781"}}